Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
PLoS Biol ; 20(12): e3001891, 2022 12.
Artículo en Inglés | MEDLINE | ID: mdl-36477165

RESUMEN

Astroglial release of molecules is thought to actively modulate neuronal activity, but the nature, release pathway, and cellular targets of these neuroactive molecules are still unclear. Pannexin 1, expressed by neurons and astrocytes, form nonselective large pore channels that mediate extracellular exchange of molecules. The functional relevance of these channels has been mostly studied in brain tissues, without considering their specific role in different cell types, or in neurons. Thus, our knowledge of astroglial pannexin 1 regulation and its control of neuronal activity remains very limited, largely due to the lack of tools targeting these channels in a cell-specific way. We here show that astroglial pannexin 1 expression in mice is developmentally regulated and that its activation is activity-dependent. Using astrocyte-specific molecular tools, we found that astroglial-specific pannexin 1 channel activation, in contrast to pannexin 1 activation in all cell types, selectively and negatively regulates hippocampal networks, with their disruption inducing a drastic switch from bursts to paroxysmal activity. This decrease in neuronal excitability occurs via an unconventional astroglial mechanism whereby pannexin 1 channel activity drives purinergic signaling-mediated regulation of hyperpolarisation-activated cyclic nucleotide (HCN)-gated channels. Our findings suggest that astroglial pannexin 1 channel activation serves as a negative feedback mechanism crucial for the inhibition of hippocampal neuronal networks.


Asunto(s)
Astrocitos , Conexinas , Modelos Animales de Enfermedad , Animales , Ratones , Conexinas/metabolismo , Astrocitos/metabolismo
2.
Int J Mol Sci ; 23(21)2022 Oct 30.
Artículo en Inglés | MEDLINE | ID: mdl-36362016

RESUMEN

Studies suggest that astrocytic connexins (Cx) have an important role in the regulation of high brain functions through their ability to establish fine-tuned communication with neurons within the tripartite synapse. In light of these properties, growing evidence suggests a role of Cx in psychiatric disorders such as major depression but also in the therapeutic activity of antidepressant drugs. However, the real impact of Cx on treatment response and the underlying neurobiological mechanisms remain yet to be clarified. On this ground, the present study was designed to evaluate the functional activity of Cx in a mouse model of depression based on chronic corticosterone exposure and to determine to which extent their pharmacological inactivation influences the antidepressant-like activity of venlafaxine (VENLA). On the one hand, our results indicate that depressed mice have impaired Cx-based gap-junction and hemichannel activities. On the other hand, while VENLA exerts robust antidepressant-like activity in depressed mice; this effect is abolished by the pharmacological inhibition of Cx with carbenoxolone (CBX). Interestingly, the combination of VENLA and CBX is also associated with a higher rate of relapse after treatment withdrawal. To our knowledge, this study is one of the first to develop a model of relapse, and our results reveal that Cx-mediated dynamic neuroglial interactions play a critical role in the efficacy of monoaminergic antidepressant drugs, thus providing new targets for the treatment of depression.


Asunto(s)
Astrocitos , Conexinas , Trastorno Depresivo , Animales , Ratones , Antidepresivos/farmacología , Antidepresivos/uso terapéutico , Astrocitos/efectos de los fármacos , Astrocitos/metabolismo , Carbenoxolona/farmacología , Conexinas/efectos de los fármacos , Conexinas/metabolismo , Fenotipo , Recurrencia , Depresión/tratamiento farmacológico , Depresión/metabolismo , Trastorno Depresivo/tratamiento farmacológico , Trastorno Depresivo/metabolismo
3.
Cereb Cortex ; 30(2): 753-766, 2020 03 21.
Artículo en Inglés | MEDLINE | ID: mdl-31271200

RESUMEN

Astrocytes play key roles in brain functions through dynamic interactions with neurons. One of their typical features is to express high levels of connexins (Cxs), Cx43 and Cx30, the gap junction (GJ)-forming proteins. Cx30 is involved in basic cognitive processes and shapes synaptic and network activities, as shown by recent studies in transgenic animals. Yet it remains unknown whether astroglial Cx30 expression, localization, and functions are endogenously and dynamically regulated by neuronal activity and could therefore play physiological roles in neurotransmission. We here show that neuronal activity increased hippocampal Cx30 protein levels via a posttranslational mechanism regulating lysosomal degradation. Neuronal activity also increased Cx30 protein levels at membranes and perisynaptic processes, as revealed by superresolution imaging. This translated at the functional level in the activation of Cx30 hemichannels and in Cx30-mediated remodeling of astrocyte morphology independently of GJ biochemical coupling. Altogether, these data show activity-dependent dynamics of Cx30 expression, perisynaptic localization, and functions.


Asunto(s)
Astrocitos/fisiología , Conexina 30/fisiología , Hipocampo/fisiología , Neuronas/fisiología , Animales , Astrocitos/citología , Femenino , Hipocampo/citología , Lisosomas/fisiología , Masculino , Ratones Endogámicos C57BL , Ratones Noqueados , Proteolisis
4.
Science ; 380(6650): 1105-1106, 2023 06 16.
Artículo en Inglés | MEDLINE | ID: mdl-37319194

RESUMEN

Serotonin induces gene expression changes in astrocytes to regulate olfactory behavior.


Asunto(s)
Astrocitos , Epigénesis Genética , Serotonina , Olfato , Astrocitos/metabolismo , Expresión Génica , Animales , Ratones
5.
Neuron ; 110(22): 3648-3650, 2022 11 16.
Artículo en Inglés | MEDLINE | ID: mdl-36395750

RESUMEN

In this issue of Neuron, Rindner et al. (2022) demonstrate that subclasses of layer 5 pyramidal neurons in the parietal cortex integrate inputs from frontal and sensory areas supralinearly and with distinct temporal dynamics.


Asunto(s)
Neuronas , Células Piramidales , Neuronas/fisiología , Células Piramidales/fisiología , Lóbulo Parietal
6.
Cells ; 9(11)2020 10 31.
Artículo en Inglés | MEDLINE | ID: mdl-33142723

RESUMEN

The metabolic syndrome, which comprises obesity and diabetes, is a major public health problem and the awareness of energy homeostasis control remains an important worldwide issue. The energy balance is finely regulated by the central nervous system (CNS), notably through neuronal networks, located in the hypothalamus and the dorsal vagal complex (DVC), which integrate nutritional, humoral and nervous information from the periphery. The glial cells' contribution to these processes emerged few year ago. However, its underlying mechanism remains unclear. Glial connexin 43 hemichannels (Cx43 HCs) enable direct exchange with the extracellular space and can regulate neuronal network activity. In the present study, we sought to determine the possible involvement of glial Cx43 HCs in energy balance regulation. We here show that Cx43 is strongly expressed in the hypothalamus and DVC and is associated with glial cells. Remarkably, we observed a close apposition of Cx43 with synaptic elements in both the hypothalamus and DVC. Moreover, the expression of hypothalamic Cx43 mRNA and protein is modulated in response to fasting and diet-induced obesity. Functionally, we found that Cx43 HCs are largely open in the arcuate nucleus (ARC) from acute mice hypothalamic slices under basal condition, and significantly inhibited by TAT-GAP19, a mimetic peptide that specifically blocks Cx43 HCs activity. Moreover, intracerebroventricular (i.c.v.) TAT-GAP19 injection strongly decreased food intake, without further alteration of glycaemia, energy expenditures or locomotor activity. Using the immediate early gene c-Fos expression, we found that i.c.v. TAT-GAP19 injection induced neuronal activation in hypothalamic and brainstem nuclei dedicated to food intake regulation. Altogether, these results suggest a tonic delivery of orexigenic molecules associated with glial Cx43 HCs activity and a possible modulation of this tonus during fasting and obesity.


Asunto(s)
Conexina 43/metabolismo , Conexina 43/fisiología , Ingestión de Alimentos , Síndrome Metabólico/metabolismo , Neuroglía/fisiología , Fragmentos de Péptidos/fisiología , Animales , Astrocitos/metabolismo , Conexina 43/síntesis química , Conexina 43/genética , Metabolismo Energético , Células Ependimogliales/metabolismo , Regulación de la Expresión Génica , Homeostasis/efectos de los fármacos , Hipotálamo/metabolismo , Masculino , Síndrome Metabólico/genética , Ratones , Ratones Endogámicos C57BL , Neuronas/metabolismo , Fragmentos de Péptidos/síntesis química , Proteínas Proto-Oncogénicas c-fos/metabolismo , Núcleo Solitario/metabolismo
7.
Brain Res Bull ; 136: 139-156, 2018 01.
Artículo en Inglés | MEDLINE | ID: mdl-28212850

RESUMEN

Astrocytes are key active elements of the brain that contribute to information processing. They not only provide neurons with metabolic and structural support, but also regulate neurogenesis and brain wiring. Furthermore, astrocytes modulate synaptic activity and plasticity in part by controlling the extracellular space volume, as well as ion and neurotransmitter homeostasis. These findings, together with the discovery that human astrocytes display contrasting characteristics with their rodent counterparts, point to a role for astrocytes in higher cognitive functions. Dysfunction of astrocytes can thereby induce major alterations in neuronal functions, contributing to the pathogenesis of several brain disorders. In this review we summarize the current knowledge on the structural and functional alterations occurring in astrocytes from the human brain in pathological conditions such as epilepsy, primary tumours, Alzheimer's disease, major depressive disorder and Down syndrome. Compelling evidence thus shows that dysregulations of astrocyte functions and interplay with neurons contribute to the development and progression of various neurological diseases. Targeting astrocytes is thus a promising alternative approach that could contribute to the development of novel and effective therapies to treat brain disorders.


Asunto(s)
Astrocitos/fisiología , Encefalopatías/fisiopatología , Encéfalo/fisiopatología , Gliosis/fisiopatología , Humanos
8.
Sci Transl Med ; 10(443)2018 05 30.
Artículo en Inglés | MEDLINE | ID: mdl-29848662

RESUMEN

Epilepsies are characterized by recurrent seizures, which disrupt normal brain function. Alterations in neuronal excitability and excitation-inhibition balance have been shown to promote seizure generation, yet molecular determinants of such alterations remain to be identified. Pannexin channels are nonselective, large-pore channels mediating extracellular exchange of neuroactive molecules. Recent data suggest that these channels are activated under pathological conditions and regulate neuronal excitability. However, whether pannexin channels sustain or counteract chronic epilepsy in human patients remains unknown. We studied the impact of pannexin-1 channel activation in postoperative human tissue samples from patients with epilepsy displaying epileptic activity ex vivo. These samples were obtained from surgical resection of epileptogenic zones in patients suffering from lesional or drug-resistant epilepsy. We found that pannexin-1 channel activation promoted seizure generation and maintenance through adenosine triphosphate signaling via purinergic 2 receptors. Pharmacological inhibition of pannexin-1 channels with probenecid or mefloquine-two medications currently used for treating gout and malaria, respectively-blocked ictal discharges in human cortical brain tissue slices. Genetic deletion of pannexin-1 channels in mice had anticonvulsant effects when the mice were exposed to kainic acid, a model of temporal lobe epilepsy. Our data suggest a proepileptic role of pannexin-1 channels in chronic epilepsy in human patients and that pannexin-1 channel inhibition might represent an alternative therapeutic strategy for treating lesional and drug-resistant epilepsies.


Asunto(s)
Encéfalo/metabolismo , Encéfalo/patología , Conexinas/metabolismo , Epilepsia/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Convulsiones/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Corteza Cerebral/patología , Modelos Animales de Enfermedad , Epilepsia/tratamiento farmacológico , Epilepsia/patología , Epilepsia del Lóbulo Temporal/metabolismo , Epilepsia del Lóbulo Temporal/patología , Humanos , Ácido Kaínico , Mefloquina/farmacología , Mefloquina/uso terapéutico , Ratones , Probenecid/farmacología , Probenecid/uso terapéutico , Convulsiones/tratamiento farmacológico , Convulsiones/patología , Transducción de Señal/efectos de los fármacos
9.
Brain Struct Funct ; 222(5): 2017-2029, 2017 07.
Artículo en Inglés | MEDLINE | ID: mdl-28280934

RESUMEN

Data collected on astrocytes' physiology in the rodent have placed them as key regulators of synaptic, neuronal, network, and cognitive functions. While these findings proved highly valuable for our awareness and appreciation of non-neuronal cell significance in brain physiology, early structural and phylogenic investigations of human astrocytes hinted at potentially different astrocytic properties. This idea sparked interest to replicate rodent-based studies on human samples, which have revealed an analogous but enhanced involvement of astrocytes in neuronal function of the human brain. Such evidence pointed to a central role of human astrocytes in sustaining more complex information processing. Here, we review the current state of our knowledge of human astrocytes regarding their structure, gene profile, and functions, highlighting the differences with rodent astrocytes. This recent insight is essential for assessment of the relevance of findings using animal models and for comprehending the functional significance of species-specific properties of astrocytes. Moreover, since dysfunctional astrocytes have been described in many brain disorders, a more thorough understanding of human-specific astrocytic properties is crucial for better-adapted translational applications.


Asunto(s)
Astrocitos/fisiología , Encefalopatías/fisiopatología , Encéfalo/fisiología , Cognición/fisiología , Animales , Astrocitos/patología , Encéfalo/patología , Encefalopatías/patología , Humanos , Neuronas/metabolismo , Neuronas/patología , Neuronas/fisiología , Sinapsis/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA